WO2001034133A3 - Oncolytic combinations for the treatment of cancer - Google Patents

Oncolytic combinations for the treatment of cancer Download PDF

Info

Publication number
WO2001034133A3
WO2001034133A3 PCT/US2000/030892 US0030892W WO0134133A3 WO 2001034133 A3 WO2001034133 A3 WO 2001034133A3 US 0030892 W US0030892 W US 0030892W WO 0134133 A3 WO0134133 A3 WO 0134133A3
Authority
WO
WIPO (PCT)
Prior art keywords
cancer
treatment
combinations
oncolytic
oncolytic combinations
Prior art date
Application number
PCT/US2000/030892
Other languages
French (fr)
Other versions
WO2001034133A2 (en
Inventor
Jason Scott Sawyer
Beverly Ann Teicher
Original Assignee
Lilly Co Eli
Jason Scott Sawyer
Beverly Ann Teicher
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli, Jason Scott Sawyer, Beverly Ann Teicher filed Critical Lilly Co Eli
Priority to AU15950/01A priority Critical patent/AU1595001A/en
Publication of WO2001034133A2 publication Critical patent/WO2001034133A2/en
Publication of WO2001034133A3 publication Critical patent/WO2001034133A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The therapeutic combinations of leukotriene (LTB4) inhibitors and anti-cancer agents are disclosed. A method of treating cancer using leukotriene (LTB4) inhibitors in conjunction with anti-cancer agents is also disclosed.
PCT/US2000/030892 1999-11-11 2000-11-09 Oncolytic combinations for the treatment of cancer WO2001034133A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU15950/01A AU1595001A (en) 1999-11-11 2000-11-09 Oncolytic combinations for the treatment of cancer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16470599P 1999-11-11 1999-11-11
US60/164,705 1999-11-11

Publications (2)

Publication Number Publication Date
WO2001034133A2 WO2001034133A2 (en) 2001-05-17
WO2001034133A3 true WO2001034133A3 (en) 2002-02-14

Family

ID=22595715

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/030892 WO2001034133A2 (en) 1999-11-11 2000-11-09 Oncolytic combinations for the treatment of cancer

Country Status (2)

Country Link
AU (1) AU1595001A (en)
WO (1) WO2001034133A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034198A2 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
JP2004529904A (en) 2001-03-14 2004-09-30 ブリストル−マイヤーズ　スクイブ　カンパニー Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
US20020183277A1 (en) * 2001-05-15 2002-12-05 Lise Binderup Combination of vitamin D analogue and pyrimidine nucleoside analogue
US20040242676A1 (en) * 2003-05-30 2004-12-02 Alessi Thomas R. Method of mitigating the adverse effects of IL-2
GB0410103D0 (en) * 2004-05-06 2004-06-09 Biolipox Ab New method
UY31952A (en) * 2008-07-02 2010-01-29 Astrazeneca Ab 5-METHYLIDENE-1,3-THIAZOLIDINE-2,4-DIONAS REPLACED AS PIM QUINASE INHIBITORS
PL388252A1 (en) * 2009-06-10 2010-12-20 Instytut Farmaceutyczny Combination therapy of colorectal cancer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998047890A1 (en) * 1997-04-21 1998-10-29 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998047890A1 (en) * 1997-04-21 1998-10-29 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation

Also Published As

Publication number Publication date
AU1595001A (en) 2001-06-06
WO2001034133A2 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
AU4564200A (en) Method for treating cancer using camptothecin derivatives and 5-fluorouracil
AU4058200A (en) Treating body tissue by applying energy and substances
AU9208498A (en) Novel apparatus and method of treating a tumor in the extremity of a patient
AU6012900A (en) Apparatus and method for treating body tissues with electricity or medicaments
WO2002005799A3 (en) Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain
HUS1500001I1 (en) Use of et743 in combination therapy with dexamethasone for treating cancer
AU2001276039A1 (en) Methods and apparatus for brachytherapy treatment of prostate disease
AU7094800A (en) Methods and apparatus for treating body tissues and bodily fluid vessels
AU2072201A (en) Agents and methods for the treatment of proliferative diseases
AU3021001A (en) Thiazolidine carboxylic acid derivatives and their use in the treatment of cancer
MY136037A (en) Biphenyl pyrimidone lp-pla2 inhibitors
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2495200A (en) Compositions and methods for the treatment of tumor
WO2001028494A3 (en) Nordihydroguaiaretic derivatives for use in treatment of tumors
WO2001034135A3 (en) Oncolytic combinations for the treatment of cancer
WO2001034133A3 (en) Oncolytic combinations for the treatment of cancer
WO2001034197A3 (en) Oncolytic combinations for the treatment of cancer
WO2002087503A3 (en) Compositions and methods for treating colorectal polyps and cancer
AU7856100A (en) Methods for treating solid tumors with irradiation and bacteria
WO2001034199A3 (en) Oncolytic combinations for the treatment of cancer
AU3270301A (en) Combined pde3 and pde4 inhibitor therapy for the treatment of obesity
AU5672000A (en) Method for detecting the effect of different chemotherapeutic agents and/or radiation therapy in malignant diseases and method for selecting more effective therapeutic agents for the therapy thereof
AU2625700A (en) Method and apparatus for treatment of tissues with fluid jets
AU2003219664A1 (en) Methods and therapeutic compositions in the treatment of advanced cancer

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase